Arxis, Inc. (ARXS) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-20

Key Insights

Multiple Arcline-affiliated entities acquired 340.7 million shares of Class B Common Stock on 04/16/2026, representing a significant concentrated ownership position and control stake in ARXS post-IPO.
The convertible common stock acquired by Arcline Double Eagle Master Fund-A LP contains substantial anti-dilution protections with conversion rights triggered at 2x the $28 IPO price, providing downside protection for this major investor.
Six reporting persons across Arcline Investment Management and two individual principals (Amara Rajeev and Shyam Ravindran) are listed as both Directors and 10% Owners, indicating tight control of the company's governance and significant alignment with institutional ownership.
The Class B Common Stock automatically converts to Class A upon transfer or specified events, suggesting a lock-up period for major shareholders and limited liquidity for insider positions in the near term.

Want the newest filings?

This analysis covers the filing from 2026-04-20. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-04-20

Jason Roth, President of Electronic Components, acquired 395,515 total shares of Class A Common Stock, including 335,515 shares from an IPO reorganization and 60,000 shares purchased at $28 per share through the directed share program, demonstrating insider confidence in the company's IPO.
Of the 335,515 reorganization shares, 204,591 remain subject to time-vesting conditions, indicating a retention mechanism that aligns management incentives with long-term company performance and locks in insider ownership for an extended period.
The purchase of 60,000 shares at $28 per share through the IPO directed share program on 04/17/2026 represents direct capital commitment by an executive officer shortly after the company's initial public offering, suggesting management confidence in the stock valuation.

Filed: 2026-04-20

Kevin Perhamus, President and CEO, acquired 3,519,533 shares of Class A Common Stock on 04/16/2026 as part of the company's IPO reorganization, with 1,357,902 shares remaining subject to time-vesting conditions, indicating significant long-term alignment with company performance.
Additional purchase of 53,600 shares at $28 per share on 04/17/2026 through the IPO directed share program demonstrates insider confidence in the company valuation immediately following the public offering.
Total beneficial ownership of 3,573,133 Class A Common Stock shares represents substantial direct ownership by the top executive, signaling strong commitment to the company's future growth and strategic direction.

Filed: 2026-04-20

Director Patrick E. Allen acquired 15,357 shares of Class A Common Stock through two transactions: 5,357 restricted stock units (vesting in one year) and 10,000 shares purchased at $28/share via the IPO directed share program, indicating insider confidence in the newly public company.
The IPO directed share program purchase of 10,000 shares at $28 suggests the company recently completed its initial public offering, with this insider participation signaling management belief in the offering price and company prospects.
The restricted stock unit award represents compensation tied to long-term vesting, aligning the director's interests with shareholder value creation over a one-year period and demonstrating standard incentive compensation practices.

Filed: 2026-04-20

Director Stephen Oetgen acquired 30,357 shares of Class A Common Stock through two transactions: 5,357 restricted stock units (RSUs) awarded with one-year vesting and 25,000 shares purchased at $28/share via the company's IPO directed share program, indicating insider confidence in the newly public company.
The IPO directed share program purchase of 25,000 shares at $28 represents significant insider investment by a director during the company's initial public offering, suggesting management belief in long-term value creation.
The filing represents Oetgen's initial beneficial ownership following Arxis, Inc.'s recent IPO (transaction dated 04/17/2026, filed 04/20/2026), with total ownership now at 30,357 shares directly held, establishing a material position in the newly public company.

Filed: 2026-04-20

Officer Ross Bradley acquired 1,090,307 shares of Class A Common Stock on 04/16/2026 as restricted stock awards related to the company's IPO reorganization, with 775,067 shares still subject to time-vesting conditions, indicating significant executive equity stake post-IPO.
Bradley made an additional open market purchase of 12,500 shares at $28/share on 04/17/2026 through the directed share program, demonstrating confidence in the stock immediately following the IPO.
The reporting person's total beneficial ownership reaches 1,102,807 shares following these transactions, establishing substantial insider ownership shortly after the company's initial public offering in April 2026.

Filed: 2026-04-20

CFO Badakhsh acquired 403,864 shares of Class A Common Stock following the company's IPO, including 367,864 restricted shares from reorganization and 36,000 shares purchased at $28 through the directed share program.
The restricted stock award of 331,080 shares remains subject to time-vesting conditions, indicating management retention incentives tied to performance milestones post-IPO.
This is an IPO-related filing showing insider participation in the directed share program, which is typical for management and generally viewed as positive confidence in the company's valuation.
The transaction dates (04/16-04/17/2026) align with the IPO process, suggesting this filing documents standard post-IPO equity grants and insider purchases rather than open market trading activity.

Filed: 2026-04-20

Jennifer Allen, Chief Legal Officer and Secretary, acquired 53,695 shares of Class A Common Stock on 04/16/2026, representing her first beneficial ownership stake in the company following the IPO reorganization.
The acquired shares are restricted stock subject to time-vesting conditions, indicating this is an equity compensation award rather than an open market purchase, which is typical for new executive positions.
This transaction reflects the company's recent initial public offering and reorganization of subsidiary equity interests into Class A Common Stock, suggesting recent capitalization restructuring.
As a C-suite executive acquiring shares post-IPO, this signals management's commitment to the company, though the restricted nature limits immediate insight into conviction levels.

Filed: 2026-04-20

Chief Accounting Officer Ryan Jankowski acquired 51,331 shares of Class A Common Stock through two transactions totaling approximately $125,000, indicating insider confidence in the company shortly after its IPO in April 2026.
The acquisition includes 46,867 restricted shares from a reorganization related to the IPO (replacing subsidiary equity interests) and 4,464 shares purchased at $28/share through the directed share program, showing mixed acquisition types aligned with IPO events.
This insider buying activity by a C-suite executive within days of the IPO filing (04/16-04/17 transactions) suggests management's conviction in the company's post-IPO value and future prospects.

Other reports for Arxis, Inc.

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.